| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.3 | 1e-09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.29 | 2e-08 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.26 | 2e-07 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.26 | 3e-07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |